查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1478664

糖尿病神經病變治療市場,佔有率,規模,趨勢,行業分析報告:依疾病類型,藥物類別,分銷管道,地區,細分市場,預測2024-2032年

Diabetic Neuropathy Treatment Market Share, Size, Trends, Industry Analysis Report, By Disorder Type; By Drug Class; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球糖尿病神經病變治療市場規模預計將達到 95.7 億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

糖尿病神經病變是由糖尿病引起的神經損傷引起的，其特徵是麻木、疼痛和無力等症狀，影響多達一半的患者。有幾個因素促進了糖尿病神經病變市場的成長。年輕人久坐的生活方式、不健康的飲食習慣和壓力引起的肥胖會增加糖尿病神經病變的風險。此外，吸菸率上升和全球糖尿病盛行率上升等因素正在擴大神經病變治療的潛在患者群體，並改變市場動態。

糖尿病盛行率的上升，加上人口老化和對糖尿病併發症認識的提高，正在推動對神經病變治療的需求。新興市場的治療選擇和治療方法的發展將進一步支持市場擴張。此外，越來越多的老年人口易患糖尿病及其併發症，這增加了對神經病變治療的需求。

政府提高人們對糖尿病認識和支持研發工作的措施也有助於市場擴張。週邊神經病變包括多種與周圍神經病變相關的疾病，隨著世界人口老化和肥胖人口的增加，週邊神經病變的情況進一步惡化。鑑於其與糖尿病的關聯，糖尿病盛行率的上升預計將在預測期內推動市場成長。

隨著糖尿病發生率的不斷增加，糖尿病常見併發症—糖尿病神經病變的發生率也不斷增加。盛行率的增加與對控制神經病理性症狀和改善患者生活品質的有效治療的需求不斷增加直接相關。此外，醫療技術和藥物研究的進步有助於開發專門針對糖尿病神經病變的創新療法和藥物，進一步推動市場成長。此外，人口老化的加劇以及肥胖和久坐生活方式等生活方式因素也促進了市場的擴張。

糖尿病神經病變治療市場報告亮點

2023年，非類固醇抗發炎藥（NSAIDs）細分市場在糖尿病神經病變治療藥物市場中佔據最大市場佔有率。非類固醇抗發炎藥通常比處方藥和醫療程序等其他治療選擇更便宜。

預計醫院部門在預測期內將以最快的複合年增長率成長。與零售藥局或其他醫療機構相比，醫院藥局可以獲得更廣泛的糖尿病神經病變藥物。

2023年，北美市場佔有率成長主要。該地區高昂的醫療費用，加上強大的保險覆蓋範圍和報銷政策，確保患者能夠獲得廣泛的糖尿病神經病變治療。

預計亞太地區糖尿病神經病變治療市場在預測期內複合年增長率將顯著成長。在亞太地區，醫療保健專業人員和一般民眾對糖尿病及其併發症（包括糖尿病神經病變）的認識不斷提高。認識的提高將促使早期診斷、積極管理以及對治療糖尿病神經病變藥物的需求增加。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第四章全球糖尿病神經病變治療市場洞察

  • 藥品類別快照
  • 糖尿病神經病變治療市場動態
    • 驅動因素和機遇
      • 全球糖尿病的盛行率正在增加，預計市場成長將加速。
      • 主要參與者擴大研發活動以推動全球糖尿病神經病變市場
    • 限制因素和課題
      • 昂貴的藥品預計將阻礙市場成長
  • PESTEL 分析
  • 糖尿病神經病變治療市場的藥物類別趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第五章全球糖尿病神經病變治療市場：依疾病類型

  • 主要發現
  • 介紹
  • 週邊神經神經病變
  • 自主神經病變
  • 近端神經神經病變
  • 局部神經病變

第六章全球糖尿病神經病變治療市場：依通路

  • 主要發現
  • 介紹
  • 局部神經障礙
  • 診所
  • 零售藥店
  • 其他

第七章全球糖尿病神經病變治療市場：依藥物類別

  • 主要發現
  • 介紹
  • 辣椒素
  • 阿片類藥物
  • 非類固醇類抗發炎藥 (NSAID)
  • 抗憂鬱藥
  • 其他

第八章全球糖尿病神經病變治療市場：依地區

  • 主要發現
  • 介紹
    • 糖尿病神經病變治療市場評估：地區，2019-2032
  • 北美
    • 北美：依疾病類型，2019-2032
    • 北美：依藥物類別，2019-2032
    • 北美：依通路劃分，2019-2032
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依疾病類型分類，2019-2032
    • 歐洲：依藥物類別，2019-2032
    • 歐洲：依通路劃分，2019-2032
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依疾病類型劃分，2019-2032
    • 亞太地區：依藥物類別，2019-2032
    • 亞太地區：依通路劃分，2019-2032
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印度尼西亞
    • 韓國
  • 中東/非洲
    • 中東和非洲：依疾病類型分類，2019-2032
    • 中東和非洲：依藥物類別劃分，2019-2032 年
    • 中東和非洲：依分銷管道劃分，2019-2032
    • 沙烏地阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疾病類型分類，2019-2032
    • 拉丁美洲：依藥物類別劃分，2019-2032
    • 拉丁美洲：依通路劃分，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • Abbott
  • Astellas Pharma Inc
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals Ltd
  • Janssen Pharmaceuticals, Inc
  • Lupin Pharmaceuticals
  • Medtronic PLC
  • Novartis
  • Pfizer. Inc
Product Code: PM4868

The global diabetic neuropathy treatment market size is expected to reach USD 9.57 billion by 2032, according to a new study by Polaris Market Research. The report "Diabetic Neuropathy Treatment Market Share, Size, Trends, Industry Analysis Report, By Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy); By Drug Class; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diabetic neuropathy, resulting from nerve damage triggered by diabetes, is characterized by symptoms like numbness, pain, and weakness, affecting up to half of those with the condition. Several factors contribute to the growth of the diabetic neuropathy market. The sedentary lifestyle, unhealthy eating habits, and stress-induced obesity in younger individuals heighten the risk of developing diabetic neuropathy. Furthermore, factors like increased smoking rates and the global prevalence of diabetes expand the prospective patient pool for neuropathy treatments, altering market dynamics.

The rising prevalence of diabetes, combined with an aging population and increased awareness of diabetic complications, drives the demand for neuropathy treatments. Advancements in treatment options and therapeutic developments further propel market expansion. Additionally, the growing geriatric population, prone to diabetes and its complications, amplifies the need for neuropathy treatments.

Government initiatives to raise diabetes awareness and support research and development efforts also contribute to market growth. Peripheral neuropathy, which encompasses various conditions involving peripheral nerve damage, is exacerbated by the global rise in geriatric and obese populations. Given its association with diabetes, the escalating prevalence of diabetes is expected to drive market growth in the forecast period.

As diabetes continues to rise, so does the incidence of diabetic neuropathy, a common complication of the disease. This increasing prevalence directly correlates with a higher demand for effective treatments to manage neuropathic symptoms and improve patient's quality of life. Additionally, advancements in medical technology and pharmaceutical research contribute to the development of innovative therapies and medications tailored specifically for diabetic neuropathy, further driving market growth. Moreover, the growing aging population, coupled with lifestyle factors such as obesity and sedentary habits, contributes to the expanding market.

Diabetic Neuropathy Treatment Market Report Highlights

In 2023, the non-steroidal anti-inflammatory drugs (NSAIDs) segment accounted for the largest market share in the diabetic neuropathy treatment market. NSAIDs are generally more affordable compared to other treatment options, such as prescription medications or medical procedures.

The hospital segment is expected to grow at the fastest CAGR during the forecast period. Hospital pharmacies may have access to a broader range of diabetic neuropathy medications than retail pharmacies or other healthcare settings.

In 2023, North America accounted for the growth of a significant market share. The region's high healthcare expenditures, coupled with robust insurance coverage and reimbursement policies, ensure that patients have access to a wide range of diabetic neuropathy treatments.

The Asia Pacific region is expected for significant growth in CAGR during the forecast period in the diabetic neuropathy treatment market. There is a growing awareness of diabetes and its complications, including diabetic neuropathy, among healthcare professionals and the general population in the Asia Pacific region. Increased awareness leads to earlier diagnosis, proactive management, and a higher demand for diabetic neuropathy treatments.

The global key market players are Abbott, Astellas Pharma Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, Glenmark Pharmaceuticals Ltd, Janssen Pharmaceuticals, Inc., Lupin Pharmaceuticals, Medtronic PLC, Novartis, Pfizer. Inc.

Polaris Market Research has segmented the diabetic neuropathy treatment market report based on disorder type, drug class, distribution channel, and region.

Diabetic Neuropathy Treatment, Disorder Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Peripheral Neuropathy
  • Autonomic Neuropathy
  • Proximal Neuropathy
  • Focal Neuropathy

Diabetic Neuropathy Treatment, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

  • Capsaicin
  • Opioid
  • Morphine
  • Others
  • Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
  • Ibuprofen
  • Naproxen
  • Others
  • Antidepressants
  • Tricyclic Antidepressants (TCAs)
  • Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Anticonvulsant Drugs
  • Other

Diabetic Neuropathy Treatment, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Other

Diabetic Neuropathy Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Diabetic Neuropathy Treatment Market Insights

  • 4.1. Diabetic Neuropathy Treatment Market - Drug Class Snapshot
  • 4.2. Diabetic Neuropathy Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of diabetes worldwide have been projected to spur market
      • 4.2.1.2. Growing research and development activities by key players to fuel the global diabetic neuropathy market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High-cost medication is expected to hinder the growth of the market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Diabetic Neuropathy Treatment Market Drug Class Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Diabetic Neuropathy Treatment Market, by Disorder Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • 5.3. Peripheral Neuropathy
    • 5.3.1. Global Diabetic Neuropathy Treatment Market, by Peripheral Neuropathy, by Region, 2019-2032 (USD Billion)
  • 5.4. Autonomic Neuropathy
    • 5.4.1. Global Diabetic Neuropathy Treatment Market, by Autonomic Neuropathy, by Region, 2019-2032 (USD Billion)
  • 5.5. Proximal Neuropathy
    • 5.5.1. Global Diabetic Neuropathy Treatment Market, by Proximal Neuropathy, by Region, 2019-2032 (USD Billion)
  • 5.6. Focal Neuropathy
    • 5.6.1. Global Diabetic Neuropathy Treatment Market, by Focal Neuropathy, by Region, 2019-2032 (USD Billion)

6. Global Diabetic Neuropathy Treatment Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Focal Neuropathy
    • 6.3.1. Global Diabetic Neuropathy Treatment Market, by Focal Neuropathy, by Region, 2019-2032 (USD Billion)
  • 6.4. Clinics
    • 6.4.1. Global Diabetic Neuropathy Treatment Market, by Clinics, by Region, 2019-2032 (USD Billion)
  • 6.5. Retail Pharmacies
    • 6.5.1. Global Diabetic Neuropathy Treatment Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.6. Other
    • 6.6.1. Global Diabetic Neuropathy Treatment Market, by Other, by Region, 2019-2032 (USD Billion)

7. Global Diabetic Neuropathy Treatment Market, by Drug Class

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • 7.3. Capsaicin
    • 7.3.1. Global Diabetic Neuropathy Treatment Market, by Capsaicin, By Region, 2019-2032 (USD Billion)
  • 7.4. Opioid
    • 7.4.1. Global Diabetic Neuropathy Treatment Market, by Opioid, By Region, 2019-2032 (USD Billion)
    • 7.4.2. Morphine
      • 7.4.2.1. Global Diabetic Neuropathy Treatment Market, by Morphine, By Region, 2019-2032 (USD Billion)
    • 7.4.3. Others
      • 7.4.3.1. Global Diabetic Neuropathy Treatment Market, by Others, By Region, 2019-2032 (USD Billion)
  • 7.5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    • 7.5.1. Global Diabetic Neuropathy Treatment Market, by Non-Steroidal Anti-inflammatory Drugs (NSAIDs), By Region, 2019-2032 (USD Billion)
    • 7.5.2. Ibuprofen
      • 7.5.2.1. Global Diabetic Neuropathy Treatment Market, by Ibuprofen, By Region, 2019-2032 (USD Billion)
    • 7.5.3. Naproxen
      • 7.5.3.1. Global Diabetic Neuropathy Treatment Market, by Naproxen, By Region, 2019-2032 (USD Billion)
    • 7.5.4. Others
      • 7.5.4.1. Global Diabetic Neuropathy Treatment Market, by Others, By Region, 2019-2032 (USD Billion)
  • 7.6. Antidepressants
    • 7.6.1. Global Diabetic Neuropathy Treatment Market, by Antidepressants, By Region, 2019-2032 (USD Billion)
    • 7.6.2. Tricyclic Antidepressants (TCAs)
      • 7.6.2.1. Global Diabetic Neuropathy Treatment Market, by Tricyclic Antidepressants (TCAs), By Region, 2019-2032 (USD Billion)
    • 7.6.3. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
      • 7.6.3.1. Global Diabetic Neuropathy Treatment Market, by Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), By Region, 2019-2032 (USD Billion)
    • 7.6.4. Selective Serotonin Reuptake Inhibitors (SSRIs)
      • 7.6.4.1. Global Diabetic Neuropathy Treatment Market, by Selective Serotonin Reuptake Inhibitors (SSRIs), By Region, 2019-2032 (USD Billion)
    • 7.6.5. Anticonvulsant Drugs
      • 7.6.5.1. Global Diabetic Neuropathy Treatment Market, by Anticonvulsant Drugs, By Region, 2019-2032 (USD Billion)
  • 7.7. Other
    • 7.7.1. Global Diabetic Neuropathy Treatment Market, by Other, By Region, 2019-2032 (USD Billion)

8. Global Diabetic Neuropathy Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Diabetic Neuropathy Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Diabetic Neuropathy Treatment Market - North America
    • 8.3.1. North America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.3.3. North America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Diabetic Neuropathy Treatment Market - U.S.
      • 8.3.4.1. U.S.: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Diabetic Neuropathy Treatment Market - Canada
      • 8.3.5.1. Canada: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Diabetic Neuropathy Treatment Market - Europe
    • 8.4.1. Europe: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Diabetic Neuropathy Treatment Market - UK
      • 8.4.4.1. UK: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Diabetic Neuropathy Treatment Market - France
      • 8.4.5.1. France: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Diabetic Neuropathy Treatment Market - Germany
      • 8.4.6.1. Germany: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Diabetic Neuropathy Treatment Market - Italy
      • 8.4.7.1. Italy: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Diabetic Neuropathy Treatment Market - Spain
      • 8.4.8.1. Spain: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Diabetic Neuropathy Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Diabetic Neuropathy Treatment Market - Russia
      • 8.4.10.1. Russia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Diabetic Neuropathy Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Diabetic Neuropathy Treatment Market - China
      • 8.5.4.1. China: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Diabetic Neuropathy Treatment Market - India
      • 8.5.5.1. India: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Diabetic Neuropathy Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Diabetic Neuropathy Treatment Market - Japan
      • 8.5.7.1. Japan: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Diabetic Neuropathy Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Diabetic Neuropathy Treatment Market - South Korea
      • 8.5.9.1. South Korea: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Diabetic Neuropathy Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Diabetic Neuropathy Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Diabetic Neuropathy Treatment Market - UAE
      • 8.6.5.1. UAE: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Diabetic Neuropathy Treatment Market - Israel
      • 8.6.6.1. Israel: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Diabetic Neuropathy Treatment Market - South Africa
      • 8.6.7.1. South Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Diabetic Neuropathy Treatment Market - Latin America
    • 8.7.1. Latin America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Diabetic Neuropathy Treatment Market - Mexico
      • 8.7.4.1. Mexico: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Diabetic Neuropathy Treatment Market - Brazil
      • 8.7.5.1. Brazil: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Diabetic Neuropathy Treatment Market - Argentina
      • 8.7.6.1. Argentina: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Astellas Pharma Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer Ingelheim GmbH
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eli Lilly and Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Glenmark Pharmaceuticals Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Janssen Pharmaceuticals, Inc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lupin Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medtronic PLC
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Novartis
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pfizer. Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 2 Global Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 3 Global Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 4 Diabetic Neuropathy Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 6 North America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 8 U.S.: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 11 Canada: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Canada: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 14 Europe: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Europe: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 17 UK: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 18 UK: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 UK: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 20 France: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 21 France: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 France: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 23 Germany: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Germany: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 26 Italy: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Italy: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 29 Spain: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Spain: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 35 Russia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Russia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 41 China: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 42 China: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 44 India: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 45 India: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 50 Japan: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 56 South Korea: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 65 UAE: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 UAE: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 68 Israel: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Israel: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 71 South Africa: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 South Africa: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 74 Latin America: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Latin America: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 77 Mexico: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Mexico: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 80 Brazil: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 83 Argentina: Diabetic Neuropathy Treatment Market, by Disorder Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Diabetic Neuropathy Treatment Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Argentina: Diabetic Neuropathy Treatment Market, by Drug Class, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Diabetic Neuropathy Treatment Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Diabetic Neuropathy Treatment Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Disorder Type
  • Figure 9. Global Diabetic Neuropathy Treatment Market, by Disorder Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Drug Class
  • Figure 11. Global Diabetic Neuropathy Treatment Market, by Drug Class, 2022 & 2032 (USD Billion)
  • Figure 12. Diabetic Neuropathy Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Diabetic Neuropathy Treatment Market